The University College London Institute of Child Health, in partnership with the University of Manchester, the Institute of Cancer Research and a consotrium of 8 other EU countries, is part of a study to research the long term effects of recombinant human growth hormone treatment on height, quality of life and general health.

The successful applicant will work with colleagues in Manchester and ICR and other EU countries to identify and contact GH treated patients now aged over 18 years to conduct the study. It is essential that the postholder has experience of working in paediatric endocrinology and growth hormone treatment management.

The deadline for applicantions is 12 November 2010. For more information please follow the link below.

Further details